Aurion Biotech has pushed out its CEO. Swiss healthcare company Alcon last week acquired a majority interest in Aurion, a clinical-stage startup in Seattle that is developing advanced cell ...

Please provide your email address to receive an email when new articles are posted on . Aurion will operate as a separate company. The Aurion board appointed Arnaud Lacoste, PhD, as CEO.

Leverages Alcon’s global scale with Aurion’s cell therapy expertise to accelerate U.S. Phase 3 development in fall of 2025 Aurion’s lead asset received Breakthrough Therapy Designation and ...

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed. Aurion will operate as ...

With this move, Alcon aims to expedite the development of Aurion’s cell therapy asset, AURN001, into Phase 3 trials in the U.S. during the second half of 2025. AURN001 has garnered Breakthrough ...

(RTTNews) - Aurion Resources Ltd. (AU.V) Wednesday has finalized an agreement with KoBold Exploration Finland Oy, a subsidiary of KoBold Metals Company, granting KoBold a 75% interest in a 35 km² ...

Aurion Resources (TSXV: AU) is teaming up with KoBold Metals, the mineral exploration company backed by Jeff Bezos and Bill Gates, to unlock the critical minerals potential of its Risti project in ...

Joint venture: Following satisfaction by KoBold of the earn-in requirements, a joint venture will be established with KoBold owning 75% and Aurion 25%. Net smelter returns royalty: In case an ...

Joint venture: Following satisfaction by KoBold of the earn-in requirements, a joint venture will be established with KoBold owning 75% and Aurion 25%. Net smelter returns royalty: In case an ...

EOH = end of hole * Intervals revised with screen fire assays since original press release. Aurion drilled six new holes, totaling 959.40 m, in the Kaaresselkä area (Figures 1-4). The holes ...

“We are delighted to welcome Don to our executive team,” said Greg Kunst, Aurion’s CEO. “Don’s track record of strategic and operational financial leadership, coupled with his extensive experience as ...

Aurion Biotech, Inc. (AURN) has filed to raise $100 million in an IPO of its common stock, according to SEC S-1 registration information. The firm is commercializing and developing treatments for ...